Wnt4, a β‐catenin activator, is highly expressed in MED12 mutant leiomyoma compared to nonmutant,11 and this mutation has been implicated with Wnt/β‐catenin pathway activation and stem cells self‐renewal, proliferation and fibrosis in ULs tissue.43 Here, WNT4 is linked to leiomyoma.